18
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Humoral Mechanisms and Clinical Aspects of Biliary Tract Motility

Pages 73-89 | Published online: 08 Jul 2009

REFERENCES

  • Ryan JP. Motility of the gallbladder and biliary tree. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven Press, 1987. p. 695–721.
  • Marzio L, Neri M, Capone F, Di Felice F, De Angelis C, Mezzetti A, et al. Gallbladder contraction and its relationship to interdigestive duodenal motor activity in normal human subjects. Dig Dis Sci 1988;33:540–4.
  • Svenberg T, Christofides ND, Fitzpatrick ML, Areola-Ortiz F, Bloom SR, Velbourn RB. Interdigestive biliary output in man: relationship to fluctuations in plasma motilin and effect of atropine. Gut 1982;23:1024–8.
  • Quist N, Oster-Jorgensen E, Pedersen SA, Rasmussen L, Hovendal C, Holst JJ. Increases in plasma motilin follow each episode of gallbladder emptying during the interdigestive period, and changes in serum bile acid concentration correlate to plasma motilin. Scand J Gastroenterol 1995;30:122–7.
  • Catalano MF, Hogan WJ. Biliary motility. Curr Opin Gastroenterol 1994;10:558–66.
  • Ivy AC, Oldberg E. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 1928;86:599–613.
  • Wiener J, Fagan CL, Lilja P, Watson LC, Thompson JC. Release of cholecystokinin in man. Correlation of blood levels with gallbladder contraction. Ann Surg 1981;194:321–5.
  • Lin TM. Actions of gastrointestinal hormones and related peptides on the motor function of the biliary tract. Gastroenterology 1975;69:1006–22.
  • Lonovics J, Nemeth J, Varro V, Greeley GH Jr, Thompson JC. Hormonal mechanisms in gallbladder motility. In: Thompson JC, editor. Gastrointestinal endocrinology. Receptors and postreceptor mechanisms. New York: Academic Press, 1990. p. 491–504.
  • Lonovics J, Gomez G. The role of gastrointestinal hormones and neuropeptides in the regulation of gallbladder motility. Cellular basis of peptide action. Regul Pept (Letter) 1991;3:65–71.
  • Toouli J, Watts JM. Actions of cholecystokinin–pancreozymin, secretin and gastrin on extra-hepatic biliary tract motility in vitro. Ann Surg 1972;175:439–47.
  • Valenzuela JE, Walsh JH, Isenberg JI. Effect of gastrin on pancreatic enzyme secretion and gallbladder emptying in man. Gastroenterology 1976;71:409–11.
  • Gullo L, Bolondi L, Priori P, Casanova P, Labo G. Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man. Digestion 1984;29:209–13.
  • Yegen B, Biren T, Onat F, Tankurt E, Gurmen N, Oftay C, et al. Modulation of gallbladder contraction by pirenzepine in humans. Am J Gastroenterol 1995;90:1489–94.
  • Vagne M, Triotskaja V. Effect of secretin, glucagon and VIP on gallbladder contraction. Digestion 1976;14:62–7.
  • Chowdhury JR, Berkowitz JM, Praissman M, Fara JW. Interaction between octapeptide–cholecystokinin, gastrin and secretin on cat gallbladder in vitro. Am J Physiol 1975;229: 1311–5.
  • Johnson AG, Marshall CE, Wilson IA. Effects of some drugs peptide hormones on the responsiveness of the rabbit isolated gallbladder to cholecystokinin. J Physiol (Lond) 1982;332: 415–25.
  • Feeley TM, Clanachan AS, Scott GW. Contractility of human gallbladder muscle in vitro. Aliment Pharmacol Ther 1987;1: 607–16.
  • Ryan J, Cohen S. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure. Gastroenterology 1977;73:870–2.
  • Strah KM, Melendez RL, Pappas TN, Debas HT. Interaction of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction. Surgery 1986; 99:469–73.
  • Kalfin R, Milenov K. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1991;100: 513–7.
  • Lonovics J, Devitt P, Rayford PL, Thompson JC. Actions of VIP, somatostatin and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro. Surg Forum 1979;30:407–9.
  • Hashimoto T, Poston GJ, Greeley GH Jr, Thompson JC. Calcitonin gene-related peptide inhibits gallbladder contractility. Surgery 1988;104:419–23.
  • Kline LW, Pang PK. Nitric oxide modulates the calcitonin gene-related peptide-induced relaxation in guinea pig gallbladder strips in vitro. Regul Pept 1994;50:207–12.
  • Lonovics J, Varro V, Thompson JC. The effect of cholecystokinin and substance P antagonists on cholecystokinin- and substance P-stimulated gallbladder contractions [abstract]. Gastroenterology 1985;88:1480.
  • Mate L, Sakamoto T, Greeley GH Jr, Thompson JC. Effect of substance P on contractions of the gallbladder. Surg Gynecol Obstet 1986;163:163–6.
  • Meldrum LA, Bojarski JC, Calam J. Effects of substance P and other neuropeptides on guinea pig gallbladder muscle. Digestion 1987;37:193–9.
  • Dahlstrand C, Bjorck S, Edin R, Dahlstrom A, Ahlman H. Substance P in the control of extrahepatic biliary motility in the cat. Regul Pept 1988;20:11–24.
  • Maggi CA, Santicioli P, Renzi D, Patacchini R, Surrenti C, Meli A. Release of substance P and calcitonin gene-related peptide-like immunoreactivity and motor response of the isolated guinea pig gallbladder to capsaicin. Gastroenterology 1989;96:1093–101.
  • Greeley GH Jr, Newman J. Enteric bombesin-like peptides. In: Thompson JC, Greeley Jr GH, Rayford PL, Townsend Jr CM, editors. Gastrointestinal endocrinology. New York: McGrawHill, 1987. p. 322–9.
  • Creutzfeldt W, Lankisch PG, Folsch UR. Hemmung der Secretin und Cholezystokinin-Pankreozymin-induzierten Saft-, und Enzymsekretion des Pancreas und der Gallenblasenkontraktion beim Menschen durch Somatostatin. Dtsch Med Wochenschr 1975;100:1135–8.
  • Fisher RS, Rock E, Levin G, Malmud L. Effects of somatostatin on gallbladder emptying. Gastroenterology 1987;92:885–90.
  • Lin TM, Chance RE. Spectrum of gastrointestinal actions of a new bovine pancreatic polypeptide (BPP). Gastroenterology 1972;62:852.
  • Lonovics J, Dewitt P, Watson LC, Rayford PL, Thompson JC. Pancreatic polypeptide. A review. Arch Surg 1981;116:1256–64.
  • Lluis F, Fujimura M, Lonovics J, Guo YS, Gomez G, Greeley GH Jr, et al. Peptide YY and gallbladder contraction. Studies in vivo and in vitro. Gastroenterology 1988;94:1441–6.
  • Guo YS, Singh P, Upp JR Jr, Thompson JC. Species-specific effects of neurotensin on gallbladder contraction in vitro. Dig Dis Sci 1989;34:21–6.
  • Walker JP, Khalil T, Wiener I, Fagan CJ, Townsend CM Jr, Greeley GH Jr, et al. The role of neurotensin in human gallbladder motility. Ann Surg 1985;201:678–83.
  • Crochelt RF, Shaw E, Peikin SR. Encephalins mediate cholecystokinin-induced gallbladder contraction in the guinea pig. Gastroenterology 1983;84:1403.
  • Takahashi T, May D, Owyang C. Cholinergic dependence of gallbladder response to cholecystokinin in the guinea pig in vivo. Am J Physiol 1991;162:4565–9.
  • Hanyu N, Dodds W, Layman R, Hogan W, Chey W, Takahashi I. Mechanism of cholecystokinin-induced contraction of the opossum gallbladder. Gastroenterology 1990;98:1299–306.
  • Grider JR. Role of cholecystokinin in the regulation of gastrointestinal motility. J Nutr 1994;124:S1334–9.
  • Steigerwalt RW, Goldfine ID, Williams JA. Characterization of cholecystokinin receptors on bovine gallbladder membranes. Am J Physiol 1984;247:G709–14.
  • Severi C. Identification of separate bombesin and substance P receptors on isolated muscle cells from canine gallbladder. J Exp Ther 1988;245:195–8.
  • Brotschi EA, LaMorte WW, Williams LF Jr. The role of extracellular calcium ion in gallbladder contractility [abstract]. Gastroenterology 1984;86:1036.
  • Ryan JP. Calcium and gallbladder smooth muscle contraction in the guinea pig: effect of pregnancy. Gastroenterology 1985; 89:1279–85.
  • Lee KY, Biancani P, Behar J. Calcium sources utilized by cholecystokinin and acetylcholine in the cat gallbladder. Am J Physiol 1989;256:G785–8.
  • Yu P, DePetris G, Biancani P, Amaral J, Behar J. Cholecystokinin-coupled intracellular signalling in human gallbladder muscle. Gastroenterology 1994;106:763–70.
  • Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1987;1: 177–85.
  • Washabau RJ, Malet PF, Khandelwal M. Human gallbladder smooth muscle contraction is mediated through myosin light chain kinase activation and myosin light chain phosphorylation [abstract]. Gastroenterology 1994;106:587.
  • Lonovics J, Nemeth J, Hulesch H, Balint GA, Varro V, Penke B. The role of calmodulin and cyclic nucleotide system in cholecystokinin-induced gallbladder contraction. In: Peptides. Chemistry, biology, interaction with proteins. Penke B, Torok A, editors. New York: Walter de Gruyter, 1988. p. 185–90.
  • Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanism of smooth muscle contraction. Physiol Rev 1996;76:967–1003.
  • Andersson KE, Andersson RG, Hedner P, Persson CG. Interrelations between cyclic AMP, cyclic GMP and contraction in guinea pig gallbladder stimulated by cholecystokinin. Life Sci 1977;20:73–8.
  • Grider JR, Murthy KS, Jin JG, Makhlouf GM. Stimulation of nitric oxide from muscle cells by VIP: prejunctional enhancement of VIP release. Am J Physiol 1992;262:G774–8.
  • Desai KM, Warner TD, Bishop AE, Polak JM, Vane JR. Nitric oxide, and not vasoactive intestinal peptide, as the main neurotransmitter of vagally induced relaxation of the guinea pig stomach. Br J Pharmacol 1994;113:1197–202.
  • Toouli J, Dodds WJ, Honda R, Sarma S, Hogan WJM, Komarowski RA. Motor function of the opossum sphincter of Oddi. J Clin Invest 1983;71:208–20.
  • Funch-Jensen P, Ebbenhoj N. Sphincter of Oddi motility. Scand J Gastroenterol 1996;31 (Suppl 216):46–51.
  • Csendes A, Kruse A, Funch-Jensen P, Oster MJ, Ornsholst J, Amdrup E. Pressure measurements in the biliary and the pancreatic duct systems in controls and in patients with gallstones, previous cholecystectomy, or common bile duct stones. Gastroenterology 1979;77:1203–10.
  • Honda R, Toouli J, Dodds WJ, Sarna S, Hogan WJ, Itoh Z. Relationship of sphincter of Oddi spike bursts to gastrointestinal myoelectric activity in conscious opossum. J Clin Invest 1982;69:770–8.
  • Faussone-Pellegrini MS. Histogenesis, structure, and relationships of interstitial cells of Cajal (ICC): from morphology to functional interpretation. Eur J Morphol 1992;30:137–48.
  • Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996;111:492–515.
  • Daniel EE, Berezin I. Interstitial cells of Cajal: are they major players in control of gastrointestinal motility? J Gastrointest Motil 1992;4:1–24.
  • Scott RB, Strasberg SM, El-Sharkawy TY, Diamant NE. Fasting canine biliary secretion and the sphincter of Oddi. Gastroenterology 1984;87:793–804.
  • Peeters TL, Vantrappen G, Janssen J. Bile acid output and the interdigestive migrating complex in normals and in cholecystectomized patients. Gastroenterology 1980;79:678–81.
  • Keane FB, DiMagno EP, Dozois rR, Go VLW. Relationship among canine interdigestive exocrine pancreatic and biliary flow, duodenal motor activity, plasma pancreatic polypeptide and motilin. Gastroenterology 1980;78:310–6.
  • Takahashi I, Honda R, Dodds WJ, Sarna S, Toouli J, Itoh Z, et al. Effect of motilin on the opossum upper gastrointestinal tract and sphincter of Oddi. Am J Physiol 1983;245:G476–81.
  • Menguy RB, Hallenbeck GA, Bollman JL, Grindlay JH. Intraductal pressures and sphincteric resistance in canine pancreatic and biliary ducts after various stimuli. Surg Gynec Obstet 1958;106:306–20.
  • Gilsdorf RB, Urdaneta LF, Leonard AS. Neuroeffector drug influences on pancreatic and biliary sphincter resistances in the awake cat. Curr Top Surg 1970;2:41–50.
  • Mori J, Azuma H, Fujiwara M. Adrenergic innervation and receptors in the sphincter of Oddi. Eur J Pharmacol 1971;14: 365–73.
  • Crema A, Benzi G, Frigo GM, Berte F. Occurence of alfa and beta receptors in the bile duct. Proc Soc Exp Biol Med 1964; 120:24–32.
  • Kyosola K. Sympatho-adrenergic neural control of the sphincter of Oddi of the cat and the dog. Tohoku J Exp Med 1979; 127:113–7.
  • Liedberg G, Persson CGA. Adrenoceptors in the cat choledochoduodenal junction studied in situ. Br J Pharmacol 1970; 39:619–26.
  • Persson CGA. Adrenoceptor functions in the cat choledochoduodenal junction in vitro. Br J Pharmacol 1971;42:447–61.
  • Persson CGA. Adrenergic, cholecystokinetic and morphineinduced effects on extrahepatic biliary motility. Acta Physiol Scand 1972;383:1–32.
  • Ingemarsson I, Liedberg G, Persson C. Effect of a beta-adrenoceptor-stimulating compound (terbutaline) on common bile duct pressure in man. Acta Chir Scand 1972;138:827–29.
  • Tansy MF, Innes DL, Martin JS, Kendall FM. An evaluation of neural influences on the sphincter of Oddi in the dog. Dig Dis Sci 1974;19:423–37.
  • Toouli J. Biliary tract motor dysfunction. In: Dent J, editor. Baillière’s clinical gastroenterology. London: Bailliere Tindall, 1991. p. 409–30.
  • Hedner P, Rorsman G. On the mechanism of action for the effect of cholecystokinin on the choledochoduodenal junction in the cat. Acta Physiol Scand 1969;76:248–54.
  • Sandblom P, Voegtlin WL, Ivy AC. The effect of cholecystokinin on the choledochoduodenal mechanism (sphincter of Oddi). Am J Physiol 1935;113:175–80.
  • Nakayama S. The effects of secretin and cholecystokinin in the sphincter muscles. In: Fuyita T, editor. Gastro-entero-pancreatic endocrine system. Tokyo: Igaku Shoin Ltd., 1973. p. 14554.
  • Lonovics J, Greeley GH Jr, Thompson JC. In vitro effects of gastrointestinal hormones on rabbit sphincter of Oddi [abstract]. Gastroenterology 1990;98:254.
  • Pauletzki JG, Sharkey KA, Davison JS, Bomzon A, Shaffer EA. Involvement of L-arginine-nitric oxide pathways in neural relaxation of the sphincter of Oddi. Eur J Pharmacol 1993; 232:263–70.
  • Thune BA, Thornell E, Svanvik J. Reflex regulation of flow resistance in the feline sphincter of Oddi by hydrostatic pressure in the biliary tree. Gastroenterology 1986;91:1364–9.
  • Muller EL, Lewinski MA, Pitt HA. The cholecysto-sphincter of Oddi reflex. J Surg Res 1984;36:377–83.
  • Lin TM, Spray GF. Effect of pentagastrin, cholecystokinin, caerulein and glucagon on the choledochal resistance and bile flow of conscious dog [abstract]. Gastroenterology 1969;56: 1178.
  • Lin TM, Spray GF. Choledochal, hepatic and cholecystokinetic actions of secretin(s): potentiation by cholecystokinin (CCK) [abstract]. Gastroenterology 1971;60:783.
  • Behar J, Biancani P. Neural control of the sphincter of Oddi. Physiologic role of enkephalins on the regulation of basal sphincter of Oddi motor activity in the cat. Gastroenterology 1984;86:134–41.
  • Varró V, Lonovics J. Sphincter of Oddi dyskinesia: pathology and clinical aspects. In: Bianchi P, editor. Topics in digestive disease 2. Cortina International Verona. New York: Raven Press, 1988. p. 357–83.
  • Lonovics J, Fujimura M, Lluis F, Mate L, Varró V, Thompson JC. Cholecystokinin-induced relaxation of the sphincter of Oddi may partially be mediated by substance P [abstract]. Gastroenterology 1985;88:1480.
  • Sievert CE Jr, Levine AS, Morley JE, Silvis SE, Vennes JA. Effect of bombesin and gastrin-releasing peptide on the canine biliary tract [abstract]. Gastroenterology 1983;84:1310.
  • Sievert CE Jr, Potter TJ, Levine AS, Morley JE, Silvis SE, Vennes JA. The mechanism of action for bombesin’s effect on canine sphincter of Oddi [abstract]. Gastroenterology 1985;88: 1586.
  • Itoh Z, Honda R, Hiwatashi K, Takeuchi S, Aizawa I, Takayanagi R, et al. Motilin-induced mechanical activity in the canine alimentary tract. Scand J Gastroenterol 1976;11 (Suppl 39):93–110.
  • Sarles JC, Delecourt P, Devaux MA, Amoros JP, Guicheney JC, Wunsch E. In vivo effect of 13-leu-motilin on the electric activity of the rabbit sphincter of Oddi. Horm Metab Res 1981;13:340–2.
  • Cushieri A, Hughes JH, Cohen M. Biliary pressure studies during cholecystectomy. Br J Surg 1972;59:267–73.
  • Toouli J, Hogan WJ, Geenan JE, Dodds WJ, Arndorfer RC. Action of cholecystokinin-octapeptide on sphincter of Oddi basal pressure and phasic wave activity in humans. Surgery 1982;92:497–503.
  • Geenan JE, Hogan WJ, Dodds WJ, Stewart ET, Arndorfer RC. Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology 1980;78:317–24.
  • Carr-Locke DL, Gregg JA, Chey WY. Effects of exogenous secretin on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma secretin levels. Dig Dis Sci 1985;30:909–17.
  • Nebel OT. Effect of enteric hormones on the human sphincter of Oddi [abstract]. Gastroenterology 1975;68:962.
  • Carr-Locke DL, Gregg JA, Aoki TT. Effects of exogenous glucagon on pancreatic and biliary ductal and sphincteric pressures in man demonstrated by endoscopic manometry and correlation with plasma glucagon. Dig Dis Sci 1983;28:312–20.
  • Cherubini M, Baxa P, Mattiussi A, Dell’Antonio A, Cataldo R, Ginanneschi U. Normal function and motor disorders of the sphincter of Oddi revealed by electronic flowgraphy. Surg Res Comm 1987;1:215–26.
  • Velosy B, Maddcsy L, Szepes A, Lonovics J, Csernay L. Comparison of the effects of octreotide and somatostatin on human sphincter of Oddi by quantitative hepatobiliary scintigraphy [abstract]. Z Gastroenterol 1996;34:339.
  • Lonovics J, Velosy B, L^ndrt S, Greeley GH Jr, Thompson J. Species differences in Oddi-sphincter responses to brain-gut peptides [abstract]. Dig Dis Sci 1990;35:6.
  • Guo Y-S, Singh P, Lluis F, Gomez G, Thompson J. Contractile response of gallbladder and sphincter of Oddi to substance P and related peptides in vitro, compared to CCK-8 [abstract]. Fed Proc 1986;45: 291.
  • Lonovics J, Lénárt Zs, Velõsy B, Németh J, Varro V, Thompson JC. Differences in the mechanism of cholecystokinin, substance P and vasoactive intestinal polypeptide induced Oddi sphincter relaxation in dogs. In: Peptides. Chemistry, biology, interaction with proteins. Penke B, Torok A, editors. New York: Walter de Gruyter, 1988. p. 171–4.
  • Dahlstrand C, Bjorck S, Edin R, Dahlstrom A, Ahlman H. Substance P in the control of extrahepatic biliary motility. Can J Physiol Pharmacol 1986;64:104–5.
  • Behar J, Biancani P. Effect of cholecystokinin and the octapeptide of cholecystokinin on the feline sphincter of Oddi and gallbladder. Mechanisms of action. J Clin Invest 1980;66: 1231–9.
  • Behar J, Biancani P. Pharmacological characterization of excitatory and inhibitory cholecystokinin (CCK) receptors of the cat gallbladder and sphincter of Oddi [abstract]. Dig Dis Sci 1984;29:8S.
  • McKirdy HC, Marshall RW, Griffin P. Effect of drugs, hormones and electrical field stimulation on isolated muscle strips from the human choledochoduodenal junction. Q J Exp Physiol 1987;72:215–25.
  • Slivka A, Chuttani R, Carr-Locke DL, Kobzik L, Bredt DS, Loscalzo J, et al. Inhibition of sphincter of Oddi function by the nitric oxide carrier S-nitroso-N-acetylcysteine in rabbits and humans. J Clin Invest 1994;94:1792–8.
  • Hirose T, Ito Y. Excitatory and inhibitory responses of Oddi’s sphincter in guinea pigs. Am J Physiol 1991;260:G615–24.
  • Lonovics J, Jakab I, Szilvdssy J, Szilvdssy Z. Regional differences in nitric oxide-mediated relaxation of the rabbit sphincter of Oddi. Eur J Pharmacol 1994;255:117–22.
  • Tanobe Y, Okamura T, Fujimura M, Toda N. Functional role and histological demonstration of nitric oxide-mediated inhibitory nerves in dog sphincter of Oddi. Neurogastroenterol Motil 1995;7:219–27.
  • Wiley JW, O’Dorioso TM, Owyang C. Vasoactive intestinal polypeptide mediates cholecystokinin-induced relaxation ofthe sphincter of Oddi. J Clin Invest 1988;81:1920–4.
  • Szilvássy Z, Nagy I, Szilvássy J, Jakab I, Csati S, Lonovics J. Impaired nitrergic relaxation of the sphincter of Oddi of hyperlipidaemic rabbits. Eur J Pharmacol 1996;301:R17–8.
  • Huizinga JD, Tomlinson J, Pintin-Quezada J. Involvement of nitric oxide in nerve mediated inhibition and action of VIP in colonic smooth muscle. J Pharmacol Exp Ther 1992;260:803–8.
  • Kanada A, Hata F, Suthamnatpong N, Maehara T, Ishi T, Takeuchi T, et al. Key roles of nitric oxide and cyclic GMP in non-adrenergic and non-cholinergic inhibition in rat ileum. Eur J Pharmacol 1992;216:287–92.
  • Vergara P, Woskowska Z, Cipris S, Fox-Threlkeld JET, Daniel EE. Mechanism of action of cholecystokinin in the canine gastrointestinal tract: role for vasoactive intestinal polypeptide and nitric oxide. J Pharmacol Exp Ther 1996;279:306–16.
  • Behar J, Biancani P. Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. Gastroeneterology 1987;92: 764–70.
  • Miyata M, Guzman S, Rayford PL, Thompson JC. Response of cholecystokinin, secretin and pancreatic secretion to graded doses of bombesin. Surg Forum 1978;29:390–2.
  • Bordley J, Olson JE. The use of glucagon in operative cholangiography. Surg Gynecol Obstet 1979;149:583–4.
  • McGammon RL, Stoelting R, Madura JA. Reversal of fentanylinduced spasm of the sphincter of Oddi. Surg Gynecol Obstet 1983;156:329–34.
  • Lonovics J, Nemeth J, Greeley GH Jr, Varro V, Thompson JC. Proposed mechanism for cholecystokinin (CCK)-, substance P (SP)-, and morphin (MO)-induced sphincter of Oddi (SO) contraction in rabbits [abstract]. Gastroenterology 1990;98: 507.
  • Lonovics J, Jakab I, Lénárt S, Velõsy B. Cyclic nucleotide level changes in the rabbit sphincter of Oddi (RSO) during vasoactive intestinal polypeptide (VIP), nitroglycerin (NG), nifedipine (NIF), isoproterenol (IPR), and aminophyllin (APH) stimulation. Z Gastroent 1991;29:193 (abstract).
  • Lonovics J, Jakab I, Lénárt S, Velõsy B, Varró V, Greeley GH Jr, Thompson JC. Pharmacomechanical coupling in the isolated rabbit sphincter of Oddi (RSO) during cholecystokinin (CCK), substance P (SP), and morphine (MO) stimulation [abstract]. Gastroenterology 1991;100:465.
  • Cox KL, von Schhrenk T, Moran TH, Gardner JD, Jensen RT. Characterization of cholecystokinin receptors on the sphincter of Oddi. Am J Physiol 1990;259:G873–81.
  • Lonovics J, Velõsy B, Madácsy L. Sphincter of Oddi dyskinesia. In: Zagoni T, editor. The papilla of Vater. Budapest: Melania Publishing Ltd., 1995. p. 125–63.
  • Shaffer EA, Bomzon A, Lax H, Davison JS. The source of calcium for CCK-induced contraction of the guinea pig gallbladder. Regul Pept 1992;37:15–26.
  • Takeda H, DelWalle J, Park J, Masterson J, Yamada T. Characterization of voltage-dependent Ca2+ channels regulating somatostatin secretion from canine fundic D-cells: studies with cholecystokinin and gastrin. Gastroenterology 1994;106: A844.
  • Parkman HP, Pagano AP, Ringold MA, Ryan JP. Effect of modulating voltage-dependent calcium channels on cholecystokinin and acethycholine-induced contraction of the guinea pig gallbladder. Regul Pept 1996;63:31–7.
  • Tsunoda I, Owyang C. Cholecystokinin receptor-coupled protein kinase mediates extracellular Ca2+ influx and sustained pancreatic amylase secretion. Gastroenterology 1994;106: A328.
  • Cheung WY. Calmodulin plays pivotal role in cellular regulation. Science 1980;207:19–27.
  • Chen Q, DePetris G, Yu P, Biancani P, Behar J. Distinct muscarinic receptors and signal transduction pathways in cat gallbladder muscle. Gastroenterology 1994;106:A477.
  • Washabau RJ, Malet PF, Khandelwal M. Human gallbladder smooth muscle contraction is mediated through myosin light chain kinase activation and myosin light chain phosphorilation. Gastroenterology 1994;106:A587.
  • Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315–24.
  • Moncada S, Palmer MJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43: 109–42.
  • Satake N, Zhou Q, Morikawa M, Inoue M, Shibata S. Potentiating effect of nicorandil, an antianginal agent, on relaxation induced by isoproterenol in isolated rat aorta: involvement of cyclic GMP-inhibitable cyclic AMP phosphodiesterase. J Cardiovasc Pharmacol 1995;25:489–94.
  • Szilvássy J, Szilvássy Z, Nagy I, Jakab I, Droy-Lefaix M-T, Lonovics J. Impairment of neural relaxation of the rabbit sphincter of Oddi tolerant to nitroglycerin [abstract]. Gastroenterology 1996;110:766.
  • Yuan X-J, Tod ML, Rubin LJ, Blaustein MP. NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltagegated K+ channels. Proc Natl Acad Sci 1996;10: 489–94.
  • Szilvássy Z, Jakab I, Lonovics J. Impairment of non-adrenergic non-cholinergic relaxation of the rabbit sphincter of Oddi tolerant to nitroglycerin. Gastroenterology 1995;108 (Suppl): A437.
  • Armstead WM. Role of ATP-sensitive K+ channel activation in cGMP-mediated pial artery vasodilation. Am J Physiol 1996;270:H423–6.
  • Najibi S, Cohen RA. Enhanced role of K+ channels in relaxation of hypercholesterolaemic rabbit carotid artery to NO. Am J Physiol 1995;269:H805–11.
  • Nakashima M, Vanhoutte PM. Isoproterenol causes hyperpolarization through opening of ATP-sensitive potassium channels in vascular smooth muscle of canine saphenous vein. J Pharmacol Exp Ther 1995;272:379–84.
  • Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Ann Rev Pharmacol Toxicol 1993;33: 597–637.
  • Szilvássy Z, Lonovics J, Jakab I, Nagy I. Glibenclamide sensitivity of neural relaxation of the rabbit sphincter of Oddi. Pharmacol Res. 1997;36:129–33.
  • Szilvássy Z, Jakab I, Lonovics J. Involvement of ATP-sensitive potassium channel opening in neural relaxation of the rabbit sphincter of Oddi. Gastroenterology 1995;108 (Suppl):A696.
  • Schneider T, Igelmund P, Hescheler J. G protein interaction with K+ and Ca2+ channels. 1997;18: 8–11.
  • Cozzolino HJ, Goldstein, Greening RR, Wirst CW. The cystic duct syndrome. JAMA 1963;185:100–4.
  • Poston GJ, Singh P, Draviam E, Yao CZ, Gomez G, Thompson JC. Early stages of gallstone formation in guinea pig are associated with decreased biliary sensitivity to cholecystokinin. Dig Dis Sci 1992;37:1236–44.
  • Maton PN, Selden AC, Fitzpatrick ML, Chadwick VS. Defective gallbladder emptying and cholecystokinin release in coeliac disease. Reversal by gluten-free diet. Gastroenterology 1985;88:391–6.
  • Pechlivanides G, Xynos E, Chrysos E, Tzovaras G, Fountos A, Vassilakis JS. Gallbladder emptying after anti-ulcer gastric surgery. Am J Surg 1994;168:335–9.
  • Everson GT, McKinley C, Lawson M, Johnson M, Kern F Jr. Gallbladder function in the human female: effect of the ovulatory cycle, pregnancy and contraceptive steroids. Gastroenterology 1982;82:711–9.
  • Stone BG, Gavaler JS, Belle SH, Shreiner DP, Peleman RR, Sarva RP, et al. Impairment of gallbladder emptying in diabetes mellitus. Gastroenterology 1988;95:170–6.
  • Palasciano G, Portincasa P, Belifiore A, Bladassare G, Cignarelli M, Peternostro A, et al. Gallbladder volume and emptying in diabetics: the role of neuropathy and obesity. J Int Med 1992;231:123–7.
  • Shaw SJ, Hajnal F, Lebovitz Y, Ralls P, Bauer M, Valenzuela J, et al. Gallbladder dysfunction in diabetes mellitus. Dig Dis Sci 1993;38:490–6.
  • De Boer SY, Masclee AAM, Lam WF, Jansen JBMJ, Lamers CBHW. Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion. Dig Dis Sci 1994;39:268–74.
  • Velõsy B, Madácsy L, Szilvássy Z, Lonovics J, Csernay L. Improvement of caerulein-induced gallbladder emptying during glyceryl trinitrate administration in patients with acalculous biliary pain measured by quantitative hepatobiliary scintigraphy [abstract]. Z Gastroenterol 1995;33:314.
  • Madácsy L, Velõsy B, Szepes A, Szilvássy Z, Pávics L, Csernay L, et al. Improvement of caerulein-induced gallbladder contraction after administration of glyceryl trinitrate in patients with acalculous biliary pain. p. in press.
  • Dodds WJ, Groh WJ, Darweesh rMa, Lawson TL, Kishk SMA, Kern MK. Sonographic measurement of gallbladder volume. Am J Radiol 1985;145:1009–11.
  • Krishnamurthy GT, Bobba VR, Kingston E. Radionuclide ejection fraction: a technique for quantitative analysis of motor function of the human gallbladder. Gastroenterology 1981;80: 482–90.
  • Fiorucci S, Scionti L, Bosso R, Desando A, Bottini P, Marino C, et al. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 1992;37:1671–7.
  • Yap L, Wycherley G, Morphett AD, Toouli J. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology 1991;101: 786–93.
  • Hogan WJ, Geenan JE. Biliary dyskinesia. Endoscopy 1988;20 (Suppl):179–83.
  • Sherman S, Troiano FP, Hawes RH. Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 1991;86:586–90.
  • Toouli J. Clinical relevance of sphincter of Oddi dysfunction. Br J Surg 1990;77:723–4.
  • Toouli J, Roberts-Thomson IC, Dent J, Lee J. Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology 1985;88:1243–50.
  • Funch-Jensen P. Sphincter of Oddi motility. Acta Chir Scand 1990;Suppl 553:1–35.
  • Scicchitano J, Saccone GTP, Baker RA, Roberts-Thomson IC, Toouli J. How safe is endoscopic sphincter of Oddi manometry? J Gastroenterol Hepatol 1995;10:334–6.
  • Zeman RK, Burell MI, Dobbins J, Jaffe MH, Choyke PL. Postcholecystectomy syndrome: evaluation using biliary scintigraphy and endoscopic retrograde cholangiography. Radiology 1985;156:787–92.
  • Shaffer EA, Herhfield NB, Logan K, Kloiber R. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi. Gastroenterology 1986;90:728–33.
  • Darweesh RMA, Dodds WJ, Hogan WJ, Geenan JE, Collier BD, Shaker R, et al. Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common bile duct obstruction. Gastroenterology 1988;94:779–86.
  • Sostre S, Kalloo AN, Spiegler EJ, Camargo EE, Wagner HN. A non-invasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med 1992;33:1216–22.
  • Cicala M, Habib FI, Scopinaro F, Fiocca F, Pallotta N, Viscardi A, et al. Relationship between extrahepatic bile transit and sphincter of Oddi motor activity in cholecystectomized subjects. Gastroenterology 1991;102:A308.
  • Madácsy L, Velõsy B, Lonovics J, Csernay L. Differentiation between organic stenosis and functional dyskinesia of the sphincter of Oddi with amyl nitrite-augmented quantitative hepatobiliary scintigraphy. Eur J Nucl Med 1994;21:203–8.
  • Varró V, Döbrönte Z, Hajnal F, Csernay L, Nemessdnyi Z, Láng J, et al. The diagnosis of hypertonic Oddi sphincter dyskinesia. Am J Gastroenterol 1983;78:736–9.
  • Steinberg WM, Salvato RF, Toskes PP. The morphineprostigmine provocative test—Is it useful for making clinical decisions? Gastroenterology 1980;78:728–32.
  • Madura JA, McCammon RL, Nakayama F. The Nardi test and biliary manometry in the diagnosis of pancreatobiliary sphincter dysfunction. Surgery 1981;90:588–95.
  • Roberts-Thomson IC, Pannal PR, Toouli J. Relationship between morphine responses and sphincter of Oddi motility in undefined biliary pain after cholecystectomy. J Gastroenterol Hepatol 1989;4:317–24.
  • Madácsy L, Velõsy B, Lonovics J, Csernay L. Evaluation of results of the prostigmine–morphine test with quantitative hepatobiliary scintigraphy: a new method for the diagnosis of sphincter of Oddi dyskinesia. Eur J Nucl Med 1995;22:227–32.
  • Geenan JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter of Oddi dysfunction. N Engl J Med 1989;320:82–7.
  • Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy—A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and non-dilated bile ducts. Gastroenterology 1991;101:1068–75.
  • Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909–18.
  • Bar-Meir S, Halpern Z, Bardan E. Nitrate therapy in a patient with papillary dysfunction. Am J Gastroenterol 1983;78:94–5.
  • Lonovics J, Velõsy B, Jakab I, Madácsy L, Hajnal F, Pap A. The effect of nitroglycerin, aminophyllin and papaverine on the prostigmine–morphine-induced sphincter of Oddi spasm in man. Hellenic J Gastroenterol 1992;5:200(A798).
  • Velõsy B, Madácsy L, Lonovics J, Csernay L. Effect of glyceryl trinitrate on the sphincter of Oddi spasm evoked by prostigmine–morphine administration. Eur J Gastroenterol Hepatol 1997;9:109–12.
  • Velõsy B, Madácsy L, Nagy I, Takács T, Máté E, Lonovics J. Prevention of octreotide-induced sphincter of Oddi spasm by glyceryl trinitrate administration in humans measured by quantitative hepatobiliary scintigraphy. Gut 1995;37 (Suppl 2):A224.
  • Guerlud M, Mendoza S, Rossiter G, Ramarez L, Barkin J. Effect of nifedipine on sphincter of Oddi motor activity: studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 1988;95:1050–5.
  • Simon L, Kovacs S. Treatment of the sphincter of Oddi dyskinesia with calcium-channel blockers. Orv Hetil 1983;124: 2805–9. In Hungarian.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.